TRT Permanent Changes: What Stays, What Reverses, and What to Expect

What Does "Permanent" Actually Mean in the Context of TRT?

The word "permanent" gets overused in TRT discussions. Most physiological changes induced by exogenous testosterone are reversible, provided the therapy is stopped under medical supervision. Two changes stand apart: prolonged testicular volume loss and durable suppression of endogenous testosterone production through the hypothalamic-pituitary-gonadal (HPG) axis. These can persist for 12 months or longer after the last injection, according to data published in the Journal of Clinical Endocrinology and Metabolism. [1]

Exogenous testosterone suppresses luteinizing hormone (LH) and follicle-stimulating hormone (FSH) by negative feedback at the pituitary. The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states: "Testosterone therapy suppresses spermatogenesis and intratesticular testosterone concentrations, effects that may not fully reverse for 6 to 18 months after discontinuation." [2] For men who want biological children in the near future, this is among the most clinically significant facts about the therapy.

Outside of those two concerns, the changes typically attributed to TRT follow a predictable timeline of onset and offset. The table below anchors the rest of this article.

Erythrocytosis (elevated hematocrit) is one area where the reversal timeline surprises patients. Red blood cell mass normalizes over roughly 3 months after stopping because erythrocyte lifespan averages 90 to 120 days. [3] Conversely, bone mineral density (BMD) gains, which require 12 to 36 months of therapy to accrue, can erode over a similar timeframe once TRT ends if the underlying hypogonadism is not addressed by another means. [4]

How Fast Does TRT Work? A Week-by-Week Breakdown

The speed of TRT's effects depends heavily on which outcome you are measuring. Sexual function and mood tend to respond first; body composition and bone density respond last.

A 2011 meta-analysis published in the Journal of Sexual Medicine, drawing on 17 randomized controlled trials (total N=862), found that libido improvements became statistically significant by week 3 of testosterone therapy, while erectile function improvements lagged by 2 to 4 weeks. [5] Energy and general well-being typically track with libido, appearing within the first 3 to 6 weeks for most patients on weekly testosterone cypionate injections of 100 to 200 mg.

Lean mass and fat mass changes require more patience. The TRAVERSE trial (N=5,204), published in the New England Journal of Medicine in 2023, documented significant improvements in body composition at 12 months in hypogonadal men randomized to testosterone gel 1.62% versus placebo. [6] Specifically, lean body mass increased by approximately 1.5 kg over placebo at 12 months, a modest but statistically significant difference (P<0.001). Fat mass decreased by roughly 1.3 kg over the same period. [6]

Bone mineral density responses are the slowest. A 2006 Cochrane review of testosterone therapy in older men with low testosterone found that lumbar spine BMD increased meaningfully only after 24 to 36 months of continuous therapy, with no significant effect detectable at 12 months. [4]

A practical week-by-week summary:

• Weeks 1, 3: Sleep quality may improve; some men notice mood stabilization
• Weeks 3, 6: Libido increases, morning erections become more frequent
• Weeks 6, 12: Physical energy and gym performance start to shift
• Months 3, 6: Body composition changes become visible
• Months 12, 36: Bone density, red blood cell mass, and full metabolic effects consolidate

Testosterone formulation affects onset speed. Testosterone cypionate (IM, weekly or biweekly) reaches steady-state serum levels within 3, 4 injection cycles. Testosterone pellets take 4 to 6 weeks to reach therapeutic levels after insertion. Testosterone nasal gel (Natesto, 11 mg TID) reaches steady-state within 7 days due to rapid absorption. [7]

Which TRT Changes Are Permanent or Very Long-Lasting?

Several changes induced by TRT can persist well beyond the therapy itself.

Testicular atrophy. Exogenous testosterone suppresses LH, eliminating the gonadotropin signal that maintains testicular volume. Studies using orchidometry show an average 20 to 30% reduction in testicular volume within 6 months of starting TRT. [8] Volume often returns partially after stopping, but full recovery is not guaranteed, particularly after multi-year use. Human chorionic gonadotropin (hCG), used concurrently at 500, 1 to 000 IU twice weekly, can preserve testicular volume during TRT. [9]

HPG axis suppression and fertility. As the Endocrine Society guideline notes, spermatogenesis recovery after TRT discontinuation takes a median of 6 months but can extend to 18 months or longer. [2] A 2013 study in the Journal of Urology (N=1,549 men with TRT-induced azoospermia) found that 67% recovered spermatogenesis within 6 months and 90% within 12 months, but roughly 10% had not recovered by 24 months. [10]

Erythrocytosis risk pattern. While the elevated hematocrit itself reverses within 90 to 120 days, men with a documented tendency toward TRT-induced erythrocytosis (hematocrit exceeding 54%) will likely experience recurrence upon restarting. This risk pattern is effectively permanent as a clinical consideration. The FDA label for testosterone cypionate injection specifically warns of this risk and requires hematocrit monitoring. [11]

Voice deepening and body hair. These androgenic effects, once they occur, are generally permanent. They are more relevant in female-to-male hormone therapy but can occur in biological males who begin TRT before voice maturation is complete. In adult men with already mature voices, further deepening is rarely clinically significant. [12]

Can You Stop TRT Cold Turkey? Why Tapering Matters

Stopping TRT abruptly is not recommended. The reason is straightforward: your pituitary and hypothalamus have downregulated LH and FSH secretion in response to exogenous testosterone. Removing that testosterone suddenly leaves a gap that your body cannot fill immediately. The result is a period of symptomatic hypogonadism that may last weeks to months. [13]

Symptoms of abrupt TRT discontinuation include severe fatigue, depression, irritability, loss of libido, and sometimes cognitive fog. These mirror the symptoms that drove many patients to seek TRT in the first place, but they can feel more acute because the HPG axis is deeply suppressed.

A supervised taper typically involves reducing weekly testosterone dose by 25% every 4 weeks while simultaneously introducing a post-cycle protocol. The two most studied options are clomiphene citrate (25 to 50 mg daily) and hCG (1,000, 1 to 500 IU every other day). Both stimulate endogenous testosterone production by acting on the HPG axis. A 2019 study in Translational Andrology and Urology found that men who used clomiphene citrate after TRT discontinuation recovered serum testosterone to baseline levels approximately 4 weeks faster than those who stopped without any PCT protocol. [13]

The AUA 2018 guideline specifically recommends offering fertility-preservation counseling before initiating TRT and monitoring LH, FSH, and total testosterone during any discontinuation attempt. [2]

Men stopping TRT because of side effects (erythrocytosis, acne, mood instability) should have those side effects addressed during the taper rather than waiting for full discontinuation. Dose reduction alone often resolves erythrocytosis without requiring complete cessation. [11]

Can You Drink Alcohol on TRT?

You can drink alcohol while on TRT, but the interaction is not neutral. Alcohol suppresses testosterone at multiple levels: it inhibits the testicular Leydig cells directly, raises cortisol (which opposes testosterone action), and increases aromatization of testosterone to estradiol. [14]

A study published in Alcohol and Alcoholism (N=66 healthy men) found that acute alcohol consumption equivalent to 0.5 g/kg body weight reduced serum testosterone by approximately 6.8% within 30 minutes of peak blood alcohol concentration. [15] Chronic moderate drinking (defined in that study as more than 14 standard drinks per week) produced a 15% reduction in mean serum testosterone compared to abstainers, an effect large enough to undermine TRT optimization.

For men on TRT, the clinical concern is threefold. First, alcohol raises estradiol through increased aromatase activity in adipose tissue. Men already managing elevated estradiol on TRT may find that regular drinking forces higher anastrozole doses or worsens estrogen-related symptoms (water retention, gynecomastia). [14] Second, alcohol increases hematocrit variability, complicating erythrocytosis monitoring. Third, alcohol disrupts sleep architecture, blunting the nocturnal growth hormone pulse and reducing the sleep-quality improvements that TRT is partly credited with producing.

No formal guideline sets a specific alcohol limit for TRT patients, but clinical consensus among endocrinologists generally aligns with the Dietary Guidelines for Americans recommendation of no more than 2 standard drinks per day for men, with 0, 1 drinks being preferable for men actively optimizing hormonal therapy. [16]

TRT and Supplements: What Helps, What Hurts, and What Is Dangerous

Supplement use on TRT is widespread but poorly studied in this specific population. Several supplements interact meaningfully with androgen physiology.

Zinc. Zinc is a cofactor in testosterone biosynthesis. A deficiency state measurably reduces serum testosterone. However, supraphysiologic zinc supplementation (above 40 mg/day) does not further increase testosterone in zinc-replete men. The NIH Office of Dietary Supplements sets the tolerable upper intake level for zinc at 40 mg/day for adults. [17] Men on TRT who are zinc-sufficient gain no additional testosterone benefit from supplementation, but supplementing at normal doses (11 mg/day for men) carries no meaningful risk.

DHEA (Dehydroepiandrosterone). DHEA is a precursor to both testosterone and estradiol. A 2006 Cochrane review found that oral DHEA supplementation at 50 mg/day raised serum DHEA-S and modestly increased estradiol in men, but did not consistently increase free testosterone. [18] For men on TRT, adding DHEA may increase estradiol load, potentially exacerbating estrogen-related side effects without adding meaningful testosterone benefit.

Ashwagandha (Withania somnifera). A double-blind RCT (N=57) published in Fertility and Sterility found that ashwagandha root extract (300 mg twice daily for 90 days) increased serum testosterone by 15% and LH by 34% in men with infertility. [19] The mechanism involves stress-axis modulation and reduced cortisol. On TRT, however, ashwagandha's mechanism of boosting endogenous LH is largely irrelevant because LH is already suppressed by exogenous testosterone. The supplement is unlikely to add testosterone on top of TRT but may help with cortisol management and stress-related fatigue.

Creatine monohydrate. Creatine does not raise testosterone directly. It increases phosphocreatine availability in muscle, improving short-burst exercise performance. A meta-analysis in the Journal of Strength and Conditioning Research (N=22 studies) confirmed no significant effect on serum testosterone. [20] Creatine is safe to combine with TRT.

Vitamin D. Vitamin D deficiency (serum 25-OH-D <20 ng/mL) is associated with lower testosterone in observational studies. A 12-month RCT (N=165) published in Hormone and Metabolic Research found that 3 to 332 IU/day of vitamin D3 increased total testosterone by 25.2% versus placebo in deficient men. [21] For TRT patients who are vitamin D deficient, correcting the deficiency is clinically worthwhile independently of TRT.

Supplements to avoid on TRT:

• St. John's Wort: induces CYP3A4 and may accelerate testosterone metabolism, reducing trough levels unpredictably [22]
• Saw palmetto: 5-alpha reductase inhibition reduces DHT conversion, which may alter androgenic side effect profiles in unpredictable ways
• Licorice root: glycyrrhizin inhibits 11-beta-hydroxysteroid dehydrogenase and has documented testosterone-lowering effects even in normal men [23]

Always disclose supplements to the prescribing physician. Several interact with both the pharmacokinetics of testosterone formulations and the laboratory assays used to monitor therapy.

Monitoring TRT: What Labs to Track and When

Monitoring on TRT is not optional. The AUA guideline recommends checking total testosterone (trough level, drawn immediately before the next injection), hematocrit, and PSA at 3 to 6 months after initiation, then annually thereafter if stable. [2]

Hematocrit above 54% is an indication to reduce dose, increase injection frequency (to reduce peak-to-trough variation), consider therapeutic phlebotomy, or pause therapy. [11] PSA rises of more than 1.4 ng/mL within any 12-month period, or a PSA above 4.0 ng/mL, warrant urology referral before continuing TRT. [2]

Estradiol (sensitive assay, not standard immunoassay) should be checked at the same intervals in men experiencing symptoms of elevated estrogen: nipple sensitivity, water retention, or mood instability. Target estradiol range on TRT is typically 20, 40 pg/mL by the sensitive LC-MS/MS assay. [24] Men with baseline BMI above 30 are at highest risk for excessive aromatization and should have estradiol checked at the 3-month visit regardless of symptoms.

A fasting lipid panel and metabolic panel are reasonable at baseline and at 12 months. The TRAVERSE trial found no statistically significant worsening of LDL cholesterol on testosterone gel versus placebo over a median 33-month follow-up. [6] HDL cholesterol may decline slightly with injectable testosterone, an effect less pronounced with topical formulations. [6]

Managing Long-Term TRT: Dose Adjustments and Realistic Expectations

TRT is an ongoing medical treatment, not a one-time intervention. Testosterone requirements can change over years due to aging, weight changes, and shifts in SHBG (sex hormone-binding globulin). A man well-controlled at 100 mg/week of testosterone cypionate at age 45 may need reassessment at 55.

A 2020 analysis in the European Journal of Endocrinology (N=411 hypogonadal men on long-term TRT, median follow-up 8 years) found that 34% required at least one dose adjustment over the study period, with increases more common than decreases. [25] SHBG tends to rise with age, reducing the free testosterone fraction and sometimes necessitating higher total testosterone targets to maintain the same free testosterone level.

The realistic long-term picture for men with confirmed primary or secondary hypogonadism is that TRT will remain necessary indefinitely unless an underlying, correctable cause of low testosterone is identified and treated. For most men with idiopathic secondary hypogonadism (low LH with low testosterone), causes such as obesity, sleep apnea, and anabolic steroid history should be addressed before TRT is considered permanent. Weight loss of 10 to 15% of body weight in obese hypogonadal men increases total testosterone by approximately 2 nmol/L on average, sufficient to normalize levels in some men without any pharmacologic intervention. [26]